Filana Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -12.8% | -12.8% | -12.1% |
| FY2022 | -33.5% | -33.5% | -32.5% |
| FY2023 | -70.7% | -70.7% | -64.1% |
| FY2024 | -16.7% | -16.7% | -15.5% |
| FY2025 | -122.3% | -122.3% | -76.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -12.8% | -12.8% | -12.1% |
| FY2022 | -33.5% | -33.5% | -32.5% |
| FY2023 | -70.7% | -70.7% | -64.1% |
| FY2024 | -16.7% | -16.7% | -15.5% |
| FY2025 | -122.3% | -122.3% | -76.9% |